Indian Patent Office Dismisses ViiV’s Controversial HIV Drug Claims
ViiV’s Application Covered Compounds Such As Cabotegravir And Dolutegravir
Years after the patent application’s initial filing in 2007, the Indian Patent Office has dismissed ViiV’s claims in response to multiple opposition filings launched against the pharma player.
